Is ACT CleanCoat™ effective against contamination from the new coronavirus (COVID-19)?
Institute for Hygiene and Microbiology Dr. Brill + Partner GmbH (Norderoog 2, D-28259 Bremen), has concluded on the efficacy of ACT CleanCoat™ against Coronavirus and Ebola, based on a poliovirus test report from 16.12.2014, adenovirus test report from 05.01.2015 and MNV test report 07.01.2015:
“After evaluation with poliovirus type 1, adenovirus type 5 and MNV the surface disinfectant CleanCoat can be declared as having “virucidal” properties according to EN 14476:2013. Therefore, after successful experiments with the three above-mentioned non-enveloped viruses the test product is also effective against the so-called blood-borne viruses including HBV, HCV and HIV as well as against members of other virus families such as orthomyxoviridae (incl. all human and animal influenza viruses like H5N1 and H1N1), coronaviridae (MERS-CoV) and filoviridae including Ebola virus.”
Is the Titanium Dioxide (TiO₂) in ACT CleanCoat™ carcinogen?
On 4 October 2019, the European Commission adopted the 14th Adaptation to Technical Progress (ATP) of the EU’s Classification and Labelling (CLP) Regulation, including the proposal to classify TiO₂ as a suspected carcinogen by inhalation.
The classification of TiO₂ is limited to powders: powder TiO₂ and mixtures placed on the market in powder form containing 1% or more of TiO₂, which is in the form of or incorporated in particles. Liquid and some solid mixtures are not classified, but specific warning statements and labels need to be applied to those that contain more than 1% TiO₂. The classification further acknowledges that this hazard only occurs under prolonged inhalation exposure to very small TiO₂ particles at an extremely high concentration.
The scope of this adaptation to EU regulation is outside of the ACT CleanCoat™ formulation, production process, and foreseeable scenarios of use, and is, therefore, irrelevant to its regulatory situation – meaning you do not get exposed to any harmful substance by touching a coated surface.
Is ACT CleanCoat™ registered by the US EPA or the US CDC?
Currently, the EPA does not have a schedule for pesticides/biocides that generate free radicals in situ. ACT.Global is working with authorities to get ACT CleanCoat™ registered as a “pesticide device”, similar to UV lights. The main ingredients (TiO₂) in ACT CleanCoat™ is on EPA’s List 4A as an inert ingredient.
Where can you coat with ACT CleanCoat™?
It is possible to coat with ACT CleanCoat™ on most indoor and outdoor surfaces, including painted walls, glass, counter tops, door handles, wooden floors, fabrics, ceramics, tiles etc. We do recommend covering expensive oil paintings, silk decor, and fine art just to be extra precautious. We do not coat humans or any other living creatures.
ACT ECA System™
What is electrolyzed water (ECA Water)?
Electrolysed water is produced by the electrolysis of water containing dissolved sodium chloride. The electrolysis of such salt solutions produces a solution of hypochlorous acid and sodium hydroxide. The resulting water can be used as a cleaning liquid and mild disinfectant. The principle was discovered by Alessandro Volta in 1800.
The term ECA Water was originally coined in Russia. In 1970, Russian scientists developed reactors that could disinfect water with just the addition of a small amount of salt. This was so successful that they developed ECA Water plants for other application fields, including drinking water disinfection in the health care sector. After the end of the Soviet Union in 1990, some of the Russian scientists involved in the ECA Water plants started to commercialize the technology. This brought the application of ECA Water to the Western world and Asia.
ECA Water, or electrolyzed water, is also called “activated water” or “superoxidized water” throughout the world and is recognized to be able to inactivate germs and viruses. In October 2002, the FDA cleared superoxidized water as a high-level disinfectant.
Superoxidized water is approved by both the EPA and CDC in the USA as a hospital grade disinfectant: https://www.cdc.gov/infectioncontrol/guidelines/disinfection/disinfection-methods/chemical.html and to be used against COVID-19: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2
Which registrations does ACT.Global have at the European Chemical Agency?
Free radicals generated in situ is the disinfecting substance of ACT CleanCoat™. ACT.Global have nine Biocidal Products Regulation EU 528/2012 (“BPR”) active substance dossiers for the use of free radicals generated in situ as active substances in biocides.
The active substance is undergoing a multi-year evaluation process in the EU. The European Biocidal Regulation allows the active substance to be legal in the market during this process if the company, as in ACT.Global’s case, has filed a dossier on the active substance in accordance with EU’s deadline.
It is, due to the comprehensive risk assessment reports submitted to the European Chemicals Agency (ECHA), expected that the active substance will be approved. All tests of the product are done by accredited third-party laboratories. COWI has provided technical advice for the preparation of the documentation package submitted to ECHA.
ACT.Global can be found on the public registers of legal suppliers in both Denmark and the EU.
Where are ACT.Global’s products manufactured?
ACT.Global has outsourced production in several markets, including Denmark. The products have obtained several patents, and several patent applications have been made. All products are third party validated and in-house quality assured. We work with our outsourcing partners to meet a growing demand.